AbbVie ABBV
NYSE ABBV
$294.88 +0.98 (+0.34%)
As of: Nov 11, 2026 · 3:59 PM EST

AbbVie (ABBV) Total Non-Current Liabilities (2012 - 2026)

Updated

AbbVie (ABBV) recorded Total Non-Current Liabilities of $117.6 billion in Q3 2026, up 12.2% from $104.84 billion a year earlier and up 10.5% from the prior quarter.

Analysis

AbbVie (ABBV) Total Non-Current Liabilities (2012 - 2026) Analysis & Trends

At the end of FY2025, AbbVie reported Total Non-Current Liabilities of $104.66 billion, up 2.9% from FY2024.

  • Annual Total Non-Current Liabilities has increased for three straight years, though with a five-year compound annual growth rate of -1.0% (FY2020 to FY2025).
  • Across earlier years, Total Non-Current Liabilities came in at $101.67 billion in FY2024 (+10.5%), $91.99 billion in FY2023 (+1.2%), $90.86 billion in FY2022 (-11.3%) and $102.39 billion in FY2021 (-6.8%).
  • The Q3 2026 figure is the highest quarterly Total Non-Current Liabilities in data going back to Q4 2012.
  • On a year-over-year basis, Total Non-Current Liabilities has increased for six consecutive quarters, with growth averaging 3.8% over the last eight quarters.
  • Peak year-over-year performance for Total Non-Current Liabilities in the last five years was growth of 21.4% in Q1 2024, against a decline of 11.3% in Q4 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at $106.4 billion (Q2 2026), $108.96 billion (Q1 2026) and $104.66 billion (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 60.81 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 102.65 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 117.60 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 79.95 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -36.84 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 76.12 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 36.05 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 96.04 Bn
10 Vertex Pharmaceuticals 138.90 Bn 106.64 Bn 2.91 Bn 10.48 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 117.60 Bn
Jun 30, 2026 106.40 Bn
Mar 31, 2026 108.96 Bn
Dec 31, 2025 104.66 Bn
Sep 30, 2025 104.84 Bn
Jun 30, 2025 105.28 Bn
Mar 31, 2025 103.51 Bn
Dec 31, 2024 101.67 Bn
Sep 30, 2024 104.32 Bn
Jun 30, 2024 102.69 Bn
Mar 31, 2024 108.05 Bn
Dec 31, 2023 91.99 Bn
Sep 30, 2023 92.45 Bn
Jun 30, 2023 90.18 Bn
Mar 31, 2023 88.99 Bn
Dec 31, 2022 90.86 Bn
Sep 30, 2022 95.08 Bn
Jun 30, 2022 97.73 Bn
Mar 31, 2022 98.87 Bn
Dec 31, 2021 102.39 Bn
API Access

AbbVie Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ABBV&period=max&api_key=YOUR_API_KEY